Tidal Therapeutics

Tidal Therapeutics is a preclinical biotechnology company headquartered at LabCentral, a shared laboratory facility in Cambridge, Massachusetts. Tidal Therapeutics uses a novel mRNA-based approach to reprogram immune cells in vivo. This technology is based on its proprietary nanoparticles, which are capable of delivering mRNA (instructions) to reprogram immune cells within the body. The technology can selectively deliver mRNA to specific types of cells in the body, with the initial application targeting specific types of immune cells.